Product Recalls In 2024 By Fda Approval

Product Recalls In 2024 By Fda Approval. The fda is reviewing the nda for vonoprazan for the treatment of heartburn associated with nonerosive gastroesophageal reflux disease. Our evaluation of drug candidates lined up for potential fda approvals in 2024 looks promising on both the innovation and market potential fronts.


Product Recalls In 2024 By Fda Approval

In 2024, the fda has recalled nearly 30 beverages due to the presence of harmful ingredients. Medical device recalls rose by 13.8% in q1 2024, indicating heightened regulatory scrutiny.

Product Recalls In 2024 By Fda Approval Images References :